Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is a pro-apoptotic protein that specifically targets tumor cells both in vitro and in vivo[7]–[10], thus making it a very promising candidate for future cancer therapy. The gene discussed is TNFSF10; the disease is neoplasm.